In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop

BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用

基本信息

  • 批准号:
    7952613
  • 负责人:
  • 金额:
    $ 12.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-14 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Currently I am using chemical genetics, siRNA screens and mass spectrometry- based proteomics to probe the Wnt/b-catenin signaling pathway. Using these techniques we identified Tec kinases as negative regulators of Wnt/b-catenin signaling. Because mutations in the Tec kinase BTK are responsible for X-linked agammaglobulinemia, we sought to corroborate our original findings in B cells. We found that Tec kinases also negatively regulate Wnt/b-catenin signaling in B cells in culture. This work has led me to the hypothesis that the interplay of Tec kinases and Wnt signaling will have a significant role in hematopoiesis in vivo. I am applying for the Pathway to Independence Award in order to extend my postdoctoral training so that I can learn about animal models of disease and hematopoiesis and gain practical knowledge of how to dissect mice and collect bone marrow, how to perform murine bone marrow transplantation experiments and how to analyze these experiments by flow cytometry. As outlined in the proposal, I will use all of these methods in order to test my hypothesis. As an independent investigator I plan to exploit my unique position at the intersection of proteomics and hematopoiesis to explore the molecular mechanisms of signal transduction in cellular differentiation. Not only would this direction allow me to fully utilize my training to date, it would allow me to enter a field that has important clinical implications, such as cord blood engraftment, bone marrow transplant and cancer treatments. PUBLIC HEALTH RELEVANCE: In addition to testing an interesting basic science hypothesis, the results of this proposal are likely to be relevant to the mission of the NHLBI in two areas: 1) informing clinicians treating patients diagnosed with X-linked agammaglobulinemia to focus attention to Wnt/b-catenin related symptoms such as colorectal carcinoma, and 2) using Tec kinase inhibition to increase the efficacy of human cord blood in clinical engraftment.
描述(申请人提供):目前我正在使用化学遗传学、siRNA筛选和基于质谱学的蛋白质组学来探索Wnt/b-catenin信号通路。利用这些技术,我们发现Tec激酶是Wnt/b-catenin信号的负调节因子。由于Tec激酶BTK的突变是X连锁无丙种球蛋白血症的原因,我们试图证实我们在B细胞上的最初发现。我们发现,在培养的B细胞中,Tec激酶也负向调节Wnt/b-catenin信号。这项工作使我产生了这样的假设,即Tec激酶和Wnt信号的相互作用将在体内的造血过程中发挥重要作用。我正在申请独立之路奖,以延长我的博士后培训,以便了解疾病和造血的动物模型,并获得如何解剖小鼠和收集骨髓、如何进行小鼠骨髓移植实验以及如何用流式细胞仪分析这些实验的实用知识。正如提案中所概述的,我将使用所有这些方法来检验我的假设。作为一名独立的研究者,我计划利用我在蛋白质组学和造血学的交叉点上的独特地位,探索细胞分化中信号转导的分子机制。这个方向不仅可以让我充分利用我迄今为止的培训,还可以让我进入一个具有重要临床意义的领域,如脐带血移植、骨髓移植和癌症治疗。 公共卫生相关性:除了检验一项有趣的基础科学假说外,这项提议的结果可能与NHLBI在两个领域的使命相关:1)告知治疗被诊断为X连锁无丙种球蛋白血症的临床医生将注意力集中在Wnt/b-catenin相关症状,如结直肠癌,以及2)使用Tec激酶抑制来提高人脐血在临床移植中的疗效。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Goff James其他文献

Richard Goff James的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Goff James', 18)}}的其他基金

Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
  • 批准号:
    10537469
  • 财政年份:
    2022
  • 资助金额:
    $ 12.71万
  • 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
  • 批准号:
    10652657
  • 财政年份:
    2022
  • 资助金额:
    $ 12.71万
  • 项目类别:
Role of Dock8 in Mucosal Immunity
Dock8 在粘膜免疫中的作用
  • 批准号:
    10198713
  • 财政年份:
    2018
  • 资助金额:
    $ 12.71万
  • 项目类别:
Role of Dock8 in Mucosal Immunity
Dock8 在粘膜免疫中的作用
  • 批准号:
    10017649
  • 财政年份:
    2018
  • 资助金额:
    $ 12.71万
  • 项目类别:
Role of Dock8 in Mucosal Immunity
Dock8 在粘膜免疫中的作用
  • 批准号:
    10440281
  • 财政年份:
    2018
  • 资助金额:
    $ 12.71万
  • 项目类别:
Role of Dock8 in Mucosal Immunity
Dock8 在粘膜免疫中的作用
  • 批准号:
    9614478
  • 财政年份:
    2018
  • 资助金额:
    $ 12.71万
  • 项目类别:
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
非霍奇金淋巴瘤伊布替尼耐药的介导机制
  • 批准号:
    9237831
  • 财政年份:
    2017
  • 资助金额:
    $ 12.71万
  • 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
  • 批准号:
    8532963
  • 财政年份:
    2010
  • 资助金额:
    $ 12.71万
  • 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
  • 批准号:
    8127876
  • 财政年份:
    2010
  • 资助金额:
    $ 12.71万
  • 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
  • 批准号:
    8514128
  • 财政年份:
    2010
  • 资助金额:
    $ 12.71万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了